Anatomic Pathology Market Worth $23.3 Billion By 2025 Due To Growing Emphasis On Biomarker-Based Pathology Tests: Grand View Research Inc.
“”Grand View Research, Inc. – Market Research And Consulting.””
According to a report published by Grand View Research, the growth of the market is driven by a growing emphasis on biomarker-based pathology tests and procedures to investigate common malignancy and tumorigenesis.
According to a report, “Anatomic Pathology Market Size, Share & Trends Analysis Report By Application (Disease Diagnosis, Drug Discovery & Development), By Product & Services, By End-use, And Segment Forecasts, 2019 – 2025” published by Grand View Research, Inc., the global anatomic pathology market size is expected to reach USD 23.3 billion by 2025, exhibiting a CAGR of 6.1% during the forecast period. The advent of technology in instruments and protocols used during anatomic pathology is anticipated to increase the adoption rate of advanced anatomic pathological instruments.
Integration of medical informatics standards for meeting specific healthcare needs by enhancing efficiency and curbing costs is a factor driving the market. Market players are collaborating for the refurbishment of pathology laboratories by incorporating innovative disease diagnostic models. This, in turn, accelerates investments toward the up-gradation of pathological equipment.
Pathology-training programs offered to pathologist trainees by public and private entities drive the anatomic pathology market. The Royal College of Pathologists, the General Medical Council, and the Association of Anatomical Pathology Technology are some organizations that have initiated several training programs and examinations to evaluate a pathologist’s knowledge and skills.
Anatomic Pathology Market Report Highlights
Technological advancements in instruments to minimize the risk of errors through the integration of novel design is expected to drive the segment to register the fastest growth rate.
On the basis of application, the disease diagnosis segment accounted for the largest revenue share in the anatomic pathology market in 2018 owing to the anatomical pathology procedures that provide researchers with an ability to investigate the etiology of diseases and related findings.
The drug discovery and development segment under application is expected to register the fastest growth over the forecast period. The growth can be attributed to the tissue analysis carried out by pathologists generates a wealth of information for pharmaceutical manufacturers during preclinical trials.
On the basis of end-use, the hospitals segment accounted for the highest market revenue share in 2018. The growth can be attributed to the high hospitalization rate of cancer patients, coupled with a substantial number of frequent readmissions in hospitals.
North America accounted for the largest market share revenue in 2018. The reason behind the growth in the region is due to the presence of major market players along with the favorable government initiatives towards pathological programs.
“Would you Like/Try a Sample Report” Click the link below:https://www.grandviewresearch.com/industry-analysis/anatomic-pathology-market/request/rs1
Anatomic Pathology Market Segmentation
Grand View Research has segmented the global anatomic pathology market report on the basis of product & services, application, end-use, and region:
Anatomic Pathology Product & Services Outlook (Revenue, USD Million, 2014 – 2025)
Instruments
Microtomes & Cryostat
Tissue processors
Automatic Stainers
Other products
Consumables
Reagents & Antibodies
Probes & Kits
Others
Services
Anatomic Pathology Application Outlook (Revenue, USD Million, 2014 – 2025)
Disease Diagnosis
Drug Discovery And Development
Others
Anatomic Pathology End-use Outlook (Revenue, USD Million, 2014 – 2025)
Hospitals
Research Laboratories
Diagnostic Laboratories
Others
Anatomic Pathology Regional Outlook (Revenue, USD Million, 2014 – 2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
China
India
Latin America
Brazil
Mexico
Middle East and Africa (MEA)
South Africa
Key Players in the Anatomic Pathology Market
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Cardinal Health
Sakura Finetek USA, Inc.
NeoGenomics Laboratories, Inc.
BioGenex
Bio SB
Have Any Query? Ask Our Experts for More Details on Report:https://www.grandviewresearch.com/inquiry/5640/ibb
Browse Related Report @
Tissue Diagnostics Market – https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research is a market research and consulting company that offers market research reports, syndicated and customized reports. The company is headquartered in San Francisco, California. It offers client engagement for business consulting and market intelligence from various domains. The clientele is based across various countries with queries coming from more than 50 industries worldwide.
Grand View Research helps its clients to make informed decisions by helping them understand current trends and scenarios. Every year Grand View Research accomplishes more than 300 multi-country market studies to optimize consulting for clients.
About Senmer News Wire
Senmer News Wire supplies premium & affordable press release publishing service from 2013, and has served thousands of clients. New service – PBN posts, Quora Answers, Yahoo Answers, High DA Profiles Backlinks, Directory Submission Service, Local Citations Service
Source: Anatomic Pathology Market Worth $23.3 Billion By 2025 Due To Growing Emphasis On Biomarker-Based Pathology Tests: Grand View Research Inc.
Comments
Post a Comment